Immix Net Invested Capital vs Property Plant And Equipment Net Analysis
| IMMX Stock | USD 2.11 0.02 0.96% |
Immix Biopharma financial indicator trend analysis is infinitely more than just investigating Immix Biopharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immix Biopharma is a good investment. Please check the relationship between Immix Biopharma Net Invested Capital and its Property Plant And Equipment Net accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.
Net Invested Capital vs Property Plant And Equipment Net
Net Invested Capital vs Property Plant And Equipment Net Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immix Biopharma Net Invested Capital account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Immix Biopharma's Net Invested Capital and Property Plant And Equipment Net is 0.47. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of Immix Biopharma, assuming nothing else is changed. The correlation between historical values of Immix Biopharma's Net Invested Capital and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Immix Biopharma are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Net Invested Capital i.e., Immix Biopharma's Net Invested Capital and Property Plant And Equipment Net go up and down completely randomly.
Correlation Coefficient | 0.47 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most indicators from Immix Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immix Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.At this time, Immix Biopharma's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 107.6 M in 2024, whereas Tax Provision is likely to drop slightly above 12.5 K in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 1.4M | 8.2M | 16.1M | 16.9M | Cost Of Revenue | 2.5K | 2.1K | 5.5K | 3.0K |
Immix Biopharma fundamental ratios Correlations
Click cells to compare fundamentals
Immix Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Immix Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immix Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immix Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immix Biopharma Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Immix Stock analysis
When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Immix Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immix Biopharma. If investors know Immix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immix Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.93) | Return On Assets (0.58) | Return On Equity (1.06) |
The market value of Immix Biopharma is measured differently than its book value, which is the value of Immix that is recorded on the company's balance sheet. Investors also form their own opinion of Immix Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Immix Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immix Biopharma's market value can be influenced by many factors that don't directly affect Immix Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immix Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immix Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immix Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.